Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST)

NCT01270893 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No particapnt recruitment.

Conditions

Gastrointestinal Cancer

Interventions

DRUG: Nilotinib

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]